The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | B | Blood and blood forming organs | |
| 2 | B03 | Antianemic preparations | |
| 3 | B03A | Iron preparations | |
| 4 | B03AA | Iron bivalent, oral preparations | |
| 5 | B03AA03 | Ferrous gluconate |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Route | Amount |
|---|---|
| ORAL - Oral | 1.7 g |
| Active Ingredient | Description | |
|---|---|---|
| Ferrous gluconate |
Iron is an essential constituent of the body, being necessary for haemoglobin formation and for the oxidative processes of living tissues. More than 80% of the iron present in the body is involved in the support of red blood cell production. Ferrous gluconate is indicated for the prevention and treatment of iron deficiency states. |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
